Mild to moderate anemia can be treated with the drug erythropoietin, which promotes the production of red blood cells in bone marrow. Iron supplementation may also be used in combination.
Pronounced thrombocytopenia carries a risk of bleeding.
For patients with severe bleeding, transfusions of red blood cells and platelets may be necessary. For some patients with low platelet counts without bleeding, a CIL-11 platelet growth factor may be appropriate.